These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein. O'Keefe JH; Cordain L; Jones PG; Abuissa H Am J Cardiol; 2006 Jul; 98(1):135-9. PubMed ID: 16784936 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and cardiovascular risk: more fuel to the fire. Boekholdt SM; Kastelein JJ Lancet; 2010 Jan; 375(9709):95-6. PubMed ID: 20031200 [No Abstract] [Full Text] [Related]
8. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy. Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222 [TBL] [Abstract][Full Text] [Related]
9. Is C-reactive protein a predictor of perioperative events before coronary artery bypass? Okamura Y Circ J; 2009 May; 73(5):818-9. PubMed ID: 19390157 [No Abstract] [Full Text] [Related]
10. C reactive protein--marker for atherothrombotic events. Gogna A; Sinha RS; Gupta B J Assoc Physicians India; 1999 Jun; 47(6):631-3. PubMed ID: 10999165 [No Abstract] [Full Text] [Related]
11. Atherosclerosis imaging and circulating blood biomarkers: insights into subclinical atherosclerotic plaque burden and disease activity. Schoenhagen P Int J Cardiovasc Imaging; 2005 Aug; 21(4):443-5. PubMed ID: 16047126 [No Abstract] [Full Text] [Related]
12. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE; Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107 [TBL] [Abstract][Full Text] [Related]
13. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2. Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T; Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012 [TBL] [Abstract][Full Text] [Related]
14. Small LDL and hsCRP as new risk factors for coronary artery disease. Brown CL; Garrett B; Superko HR J Med Assoc Ga; 2001 Dec; 90(4):11-6. PubMed ID: 11845678 [No Abstract] [Full Text] [Related]
15. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704 [TBL] [Abstract][Full Text] [Related]
16. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. Tani S; Matsumoto M; Nagao K; Hirayama A J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623 [TBL] [Abstract][Full Text] [Related]